Literature DB >> 19060539

Cardiac regeneration and stem cell therapy.

Joshua M Hare1, Sandra V Chaparro.   

Abstract

PURPOSE OF REVIEW: Significant recent developments have occurred in the field of cardiac regeneration and stem-cell therapy. Understanding the new technological advances in cell therapy will ultimate allow us to achieve a goal of cell-based cardiac repair. RECENT
FINDINGS: We discuss the latest cell-based therapies (including skeletal myoblasts, bone-marrow-derived cells, stem cells), the recent clinical trials in humans and different delivery techniques.
SUMMARY: Ongoing unraveling of the mechanistic and clinical complexities underlying cardiac regeneration will advance the field of regenerative medicine. Substantial progress is being made by the parallel conduct of basic science studies and clinical trials that are incorporating mechanistic evaluations.

Entities:  

Mesh:

Year:  2008        PMID: 19060539      PMCID: PMC3966209          DOI: 10.1097/MOT.0b013e32830fdfc4

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  33 in total

1.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

2.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

Review 3.  Plasticity of adult stem cells.

Authors:  Amy J Wagers; Irving L Weissman
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

4.  Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

Authors:  Bodo E Strauer; Michael Brehm; Tobias Zeus; Thomas Bartsch; Christina Schannwell; Christine Antke; Rüdiger V Sorg; Gesine Kögler; Peter Wernet; Hans-Wilhelm Müller; Matthias Köstering
Journal:  J Am Coll Cardiol       Date:  2005-11-01       Impact factor: 24.094

5.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

6.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

7.  Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium.

Authors:  Yao Liang Tang; Qiang Zhao; Y Clare Zhang; Leilei Cheng; Mingya Liu; Jianhui Shi; Yin Zeng Yang; Chuizhen Pan; Junbo Ge; M Ian Phillips
Journal:  Regul Pept       Date:  2004-01-15

8.  Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.

Authors:  Dietlind Zohlnhöfer; Alban Dibra; Tobias Koppara; Antoinette de Waha; Rasmus Sejersten Ripa; Jens Kastrup; Marco Valgimigli; Albert Schömig; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

9.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.

Authors:  Hyun-Jae Kang; Hyo-Soo Kim; Shu-Ying Zhang; Kyung-Woo Park; Hyun-Jai Cho; Bon-Kwon Koo; Yong-Jin Kim; Dong Soo Lee; Dae-Won Sohn; Kyou-Sup Han; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

View more
  25 in total

Review 1.  Phenotyping patient-derived cells for translational studies in cardiovascular disease.

Authors:  Stanley Y Shaw; Ari D Brettman
Journal:  Circulation       Date:  2011-11-29       Impact factor: 29.690

2.  Induction of cardiac myogenic lineage development differs between mesenchymal and satellite cells and is accelerated by bone morphogenetic protein-4.

Authors:  Liliana Grajales; Jesús García; David L Geenen
Journal:  J Mol Cell Cardiol       Date:  2012-06-16       Impact factor: 5.000

Review 3.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

Authors:  Vincenzo Lionetti; Giacomo Bianchi; Fabio A Recchia; Carlo Ventura
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 4.  Imaging approaches for the study of cell-based cardiac therapies.

Authors:  Joe F Lau; Stasia A Anderson; Eric Adler; Joseph A Frank
Journal:  Nat Rev Cardiol       Date:  2009-12-22       Impact factor: 32.419

Review 5.  Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy.

Authors:  Parisa Lotfinegad; Karim Shamsasenjan; Aliakbar Movassaghpour; Jafar Majidi; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-12-23

Review 6.  Current perspectives on imaging cardiac stem cell therapy.

Authors:  Joseph C Wu; M Roselle Abraham; Dara L Kraitchman
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

7.  Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

Authors:  Henry C Quevedo; Konstantinos E Hatzistergos; Behzad N Oskouei; Gary S Feigenbaum; Jose E Rodriguez; David Valdes; Pradip M Pattany; Juan P Zambrano; Qinghua Hu; Ian McNiece; Alan W Heldman; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-05       Impact factor: 11.205

Review 8.  Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing.

Authors:  Alexander R Badiavas; Evangelos V Badiavas
Journal:  Expert Opin Biol Ther       Date:  2011-08-20       Impact factor: 4.388

9.  Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells.

Authors:  Jaeyeaon Cho; Pranela Rameshwar; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

10.  Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches.

Authors:  L M Popescu; Mihaela Gherghiceanu; C G Manole; Maria Simonetta Faussone-Pellegrini
Journal:  J Cell Mol Med       Date:  2009-04-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.